» Articles » PMID: 9450576

Body Mass Index and Risk of Adenocarcinomas of the Esophagus and Gastric Cardia

Overview
Specialty Oncology
Date 1998 Feb 5
PMID 9450576
Citations 167
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Incidence rates have risen rapidly for esophageal adenocarcinoma and moderately for gastric cardia adenocarcinoma, while rates have remained stable for esophageal squamous cell carcinoma and have declined steadily for noncardia gastric adenocarcinoma. We examined anthropometric risk factors in a population-based case-control study of esophageal and gastric cancers in Connecticut, New Jersey, and western Washington.

Methods: Healthy control subjects (n = 695) and case patients with esophageal squamous cell carcinoma or noncardia gastric adenocarcinoma (n = 589) were frequency-matched to case patients with adenocarcinomas of esophagus or gastric cardia (n = 554) by 5-year age groups, sex, and race (New Jersey only). Classification of cases by tumor site of origin and histology was determined by review of pathology materials and hospital records. Data were collected using in-person structured interviews. Associations with obesity, measured by body mass index (BMI), were estimated by odds ratios (ORs). All ORs were adjusted for geographic location, age, sex, race, cigarette smoking, and proxy response status.

Results: The ORs for esophageal adenocarcinoma rose with increasing adult BMI. The magnitude of association with BMI was greater among the younger age groups and among nonsmokers. The ORs for gastric cardia adenocarcinoma rose moderately with increasing BMI. Adult BMI was not associated with risk of esophageal squamous cell carcinoma or noncardia gastric adenocarcinoma.

Conclusions: Increasing prevalence of obesity in the United States population may have contributed to the upward trends in esophageal and gastric cardia adenocarcinomas.

Citing Articles

Causal association of gut microbiota and esophageal cancer: a Mendelian randomization study.

Gao X, Wang Z, Liu B, Cheng Y Front Microbiol. 2023; 14:1286598.

PMID: 38107856 PMC: 10722290. DOI: 10.3389/fmicb.2023.1286598.


Risk Factors Related to Esophageal Cancer, a Case-Control Study in Herat Province of Afghanistan.

Eser S, Ozgur S, Shayan N, Abdianwall M Arch Iran Med. 2023; 25(10):682-690.

PMID: 37542400 PMC: 10685874. DOI: 10.34172/aim.2022.107.


Use of proton pump inhibitors for the risk of gastric cancer.

Gao H, Li L, Geng K, Teng C, Chen Y, Chu F Medicine (Baltimore). 2023; 101(49):e32228.

PMID: 36626449 PMC: 9750528. DOI: 10.1097/MD.0000000000032228.


Research progress in the role of CD38 in clinical tumor treatment.

He Z, Liu X, Zhou Y Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022; 47(7):952-959.

PMID: 36039593 PMC: 10930288. DOI: 10.11817/j.issn.1672-7347.2022.210351.


Inverse Association Between Gluteofemoral Obesity and Risk of Non-Cardia Gastric Intestinal Metaplasia.

Jove A, Holmes H, Tan M, El-Serag H, Thrift A Clin Gastroenterol Hepatol. 2022; 21(1):64-71.

PMID: 35569739 PMC: 9653509. DOI: 10.1016/j.cgh.2022.04.033.